
Gala GLP-1 is a telehealth platform that provides personalized GLP-1 medication for weight loss, integrating AI technology for dosage tracking and lifestyle guidance. With a network of over 20,000 clinicians across all 50 states, Gala GLP-1 offers continuous support and a user-friendly app to help patients manage their weight loss journey effectively. The company has reported 25,000 success stories, showcasing its impact in the weight loss market.

Gala GLP-1 is a telehealth platform that provides personalized GLP-1 medication for weight loss, integrating AI technology for dosage tracking and lifestyle guidance. With a network of over 20,000 clinicians across all 50 states, Gala GLP-1 offers continuous support and a user-friendly app to help patients manage their weight loss journey effectively. The company has reported 25,000 success stories, showcasing its impact in the weight loss market.
Operator: AI Coaching Inc. (Delaware) doing business as Gala GLP-1
Product: Telehealth weight-loss service delivering clinician-supervised GLP-1 medications plus a tracker app for dosing, side effects, and progress
Pricing: $179/mo advertised on the homepage; some program pages state $199/mo
Funding: Pre-Seed round announced 2024-12-16; investor: Antler; amount undisclosed
Scale / claims: Reports a network of over 20,000 clinicians across all 50 states and 25,000 success stories
Weight-loss treatment and adherence support using GLP-1 medications (e.g., semaglutide, tirzepatide).
2023
Telehealth
Amount undisclosed
“Antler participated in a Pre-Seed round announced 2024-12-16”